iSpecimen Common Stock

iSpecimen (ISPC) currently reports a common stock of $150 as of June 2026. That compares with $250 in the prior-year period — down 39.2% year over year. Use the charts on this page to explore iSpecimen's common stock history and peer comparisons.

iSpecimen's common stock decreased from $250 to $150 — a 39.2% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

iSpecimen reported $150 in common stock as of June 2026. That compares with $250 in the prior-year period — down 39.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $150, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for iSpecimen, and consider following ISPC for alerts when major investors trade the stock.

iSpecimen is classified in the Healthcare sector. On common stock, it currently shows $150. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ISPC with unrelated industries.